The role of the gut microbiome and the gut–lung axis in the allergic bronchial asthma: strategies for prevention and personalized therapy in primary care practice

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Allergic bronchial asthma is one of the most significant healthcare challenges, with high comorbidity with other atopic conditions, as reflected in the “unified airway” concept.

This review focuses on the analysis of current evidence regarding the role of the gut–lung axis—a bidirectional communication system that integrates immunological, metabolic, and microbial interactions between the gastrointestinal microbiota and the respiratory system. The article thoroughly examines the influence of perinatal factors on early microbiome development, a critical period for immune maturation. Meta-analyses confirm that cesarean delivery, lack of breastfeeding, and early antibiotic use significantly increase asthma and atopic march risk.

Particular attention is paid to the mechanisms by which gut dysbiosis contributes to Th2-mediated inflammation, including impaired short-chain fatty acids production, lymphocyte migration, and systemic circulation of proinflammatory cytokines.

The article systematizes the evidence supporting the efficacy of microbiome-oriented prevention and therapy strategies. It has been established that specific probiotic strains, such as Lactobacillus rhamnosus HN001 and Bifidobacterium lactis Probio-M8, as well as bacterial lysates (OM-85), improve disease control and reduce the frequency of exacerbations. For primary care physicians, we define patient selection criteria for adjuvant therapy, including those with resistant asthma, gastrointestinal comorbidity, and recurrent respiratory infections. Dietary interventions, namely the Mediterranean diet and fiber intake (25–35 g/day), also show protective effects via immune modulation.

Despite the absence of clear algorithms in current Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines, these data substantiate the need to integrate microbiome assessment and corresponding nutritional and metabolic corrections into routine clinical practice to improve allergic bronchial asthma management. The authors conclude that modification of early risk factors and personalized correction of microbiota composition open new prospects for primary prevention and personalized treatment of respiratory allergies.

Full Text

Restricted Access

About the authors

Alena D. Shatunova

Bashkir State Medical University

Author for correspondence.
Email: shatu-shatu@mail.ru
ORCID iD: 0009-0007-6451-2127
Russian Federation, Ufa

Serafim V. Ermolaev

City Polyclinic No. 7, Kazan

Email: sima_ermolaev@mail.ru
ORCID iD: 0009-0008-6082-8359
Russian Federation, Kazan

Adelya R. Zakirova

Kazan State Medical University

Email: adelazakirova144@gmail.com
ORCID iD: 0009-0000-3427-7989
Russian Federation, Kazan

Maria V. Kuklikhina

Kazan State Medical University

Email: mkuklikhina@bk.ru
ORCID iD: 0009-0004-7671-113X
Russian Federation, Kazan

Kseniya A. Ekkemeeva

Kazan State Medical University

Email: die_gelassenheit@vk.com
ORCID iD: 0009-0006-6075-4754
Russian Federation, Kazan

Yuliya E. Danilenko

Kuban State Medical University

Email: Marikki@mail.ru
ORCID iD: 0009-0005-6301-1043
Russian Federation, Krasnodar

Dmitry A. Maslov

Kuban State Medical University

Email: asimplesmile0@gmail.com
ORCID iD: 0009-0009-9758-0526
Russian Federation, Krasnodar

Irina V. Bryk

Kuban State Medical University

Email: iribryk@mail.ru
ORCID iD: 0009-0009-7407-3812
Russian Federation, Krasnodar

Amalia S. Gusikova

Kuban State Medical University

Email: agusikova123@mail.ru
ORCID iD: 0009-0006-0212-3292
Russian Federation, Krasnodar

Aleksandra S. Lapushkina

Rostov State Medical University

Email: alex4.lapushka@yandex.ru
ORCID iD: 0009-0008-8540-8465
Russian Federation, Rostov-on-Don

Zelimkhan R. Baskhanov

Rostov State Medical University

Email: 95bashanov200295@gmail.com
ORCID iD: 0009-0008-0211-5940
Russian Federation, Rostov-on-Don

Sofia A. Chumakova

Rostov State Medical University

Email: ChumakovaSonya2003@bk.ru
ORCID iD: 0009-0008-3351-7678
Russian Federation, Rostov-on-Don

References

  1. Rogliani P, Laitano R, Ora J, et al. Strength of association between comorbidities and asthma: a meta-analysis. Eur Respir Rev. 2023;32(167):220202. doi: 10.1183/16000617.0202-2022
  2. Chinratanapisit S, Suratannon N, Pacharn P, et al. Prevalence and severity of asthma, rhinoconjunctivitis and eczema in children from the Bangkok area: the Global Asthma Network (GAN) Phase I. Asian Pac J Allergy Immunol. 2019;37(4):226–231. doi: 10.12932/AP-120618-0336
  3. Chinratanapisit S, Suratannon N, Pacharn P, et al. Prevalence and risk factors of allergic rhinitis in children in Bangkok area. Asian Pac J Allergy Immunol. 2019;37(4):232–239. doi: 10.12932/AP-120618-0337
  4. Duong QA, Pittet LF, Curtis N, Zimmermann P. Antibiotic exposure and adverse long-term health outcomes in children: a systematic review and meta-analysis. J Infect. 2022;85(3):213–300. doi: 10.1016/j.jinf.2022.01.005 EDN: FEOSKF
  5. Song M, Hwang S, Son E, et al. Geographical differences of risk of asthma and allergic rhinitis according to urban/rural area: a systematic review and meta-analysis of cohort studies. J Urban Health. 2023;100(3):478–492. doi: 10.1007/s11524-023-00735-w EDN: AWNOZL
  6. Wang X, Zhou N, Zhi Yu. Association between exposure to greenness and atopic march in children and adults: a systematic review and meta-analysis. Front Public Health. 2023;10:1097486. doi: 10.3389/fpubh.2022.1097486 EDN: YAHJVV
  7. Zhang ZQ, Li JY, Guo Q, et al. Association between air pollution and allergic upper respiratory diseases: a meta-analysis. Eur Respir Rev. 2025;34(176):240066. doi: 10.1183/16000617.0066-2024
  8. Wong QYA, Chew FT. The association between migration and prevalence of allergic diseases: a systematic review and meta-analysis. Int Arch Allergy Immunol. 2024;185(11):1099–1122. doi: 10.1159/000539382 EDN: OJJWUG
  9. Druszczynska M, Sadowska B, Kulesza J, et al. The intriguing connection between the gut and lung microbiomes. Pathogens. 2024;13(11):1005. doi: 10.3390/pathogens13111005 EDN: EVMVTT
  10. Pan J, Zhang Y, Qiu S, et al. Gut microbiome dysbiosis in chronic lung disease: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2025;15:1554846. doi: 10.3389/fcimb.2025.1554846 EDN: IXXJUS
  11. Koefoed HJL, Zwitserloot AM, Vonk JM, Koppelman GH. Asthma, bronchial hyperresponsiveness, allergy and lung function development until early adulthood: a systematic literature review. Pediatr Allergy Immunol. 2021;32(6):1238–1254. doi: 10.1111/pai.13516 EDN: QMWBYY
  12. Brożek JL, Agarwal A, Brignardello-Petersen R, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi: 10.1016/j.jaci.2017.03.050 EDN: YDTHOX
  13. Alcazar CGM, Paes VM, Shao Y, et al. The association between early-life gut microbiota and childhood respiratory diseases: a systematic review. Lancet Microbe. 2022;3(11):e867–e880. doi: 10.1016/S2666-5247(22)00184-7 EDN: PVULYI
  14. Hufnagl K, Pali-Schöll I, Roth-Walter F, Jensen-Jarolim E. Dysbiosis of the gut and lung microbiome has a role in asthma. Semin Immunopathol. 2020;42(1):75–93. doi: 10.1007/s00281-019-00775-y EDN: XARPVD
  15. Abdel-Aziz MI, Vijverberg SJ, Neerincx AH, et al. The crosstalk between microbiome and asthma: exploring associations and challenges. Clin Exp Allergy. 2019;49(8):1067–1086. doi: 10.1111/cea.13444 EDN: WSQMGB
  16. Fujimura KE, Sitarik AR, Havstad S, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T-cell differentiation. Nat Med. 2016;22(10):1187–1191. doi: 10.1038/nm.4176
  17. Agarwal S, Tomar N, Makwana M, et al. Air pollution, dysbiosis and diseases: pneumonia, asthma, COPD, lung cancer and irritable bowel syndrome. Future Microbiol. 2024;19(17):1497–1513. doi: 10.1080/17460913.2024.2401263 EDN: FLDBTE
  18. Kermani NZ, Li CX, Versi A, et al. Endotypes of severe neutrophilic and eosinophilic asthma from multi-omics integration of U-BIOPRED sputum samples. Clin Transl Med. 2024;14(7):e1771. doi: 10.1002/ctm2.1771 EDN: KQYFNM
  19. Shenhav L, Fehr K, Reyna ME, et al. Microbial colonization programs are structured by breastfeeding and guide healthy respiratory development. Cell. 2024;187(19):5431–5452.e20. doi: 10.1016/j.cell.2024.07.022 EDN: GFDWHQ
  20. Stickley SA, Fang ZY, Ambalavanan A, et al. Gene-by-environment interactions modulate the infant gut microbiota in asthma and atopy. J Allergy Clin Immunol. 2025;156(2):433–448. doi: 10.1016/j.jaci.2025.03.018
  21. Keag OE, Norman JE, Stock SJ. Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: systematic review and meta-analysis. PLoS Med. 2018;15(1):e1002494. doi: 10.1371/journal.pmed.1002494
  22. Darabi B, Rahmati S, Hafezi Ahmadi MR, et al. The association between caesarean section and childhood asthma: an updated systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2019;15(1):1–13. doi: 10.1186/s13223-019-0367-9 EDN: FCHPTX
  23. Zhong Z, Chen M, Dai S, et al. Association of cesarean section with asthma in children/adolescents: a systematic review and meta-analysis based on cohort studies. BMC Pediatr. 2023;23(1):571. doi: 10.1186/s12887-023-04396-1 EDN: DFPQSJ
  24. Yu HZ, Wang XW, Guo ZY, et al. Association of caesarean delivery with offspring health outcomes in full-cohort versus sibling-comparison studies: a comparative meta-analysis and simulation study. BMC Med. 2023;21(1):348. doi: 10.1186/s12916-023-03030-2 EDN: QESXYO
  25. Güngör D, Nadaud P, LaPergola CC, et al. Infant milk-feeding practices and food allergies, allergic rhinitis, atopic dermatitis, and asthma throughout the life span: a systematic review. Am J Clin Nutr. 2019;109(Suppl_7):772S–799S. doi: 10.1093/ajcn/nqy283
  26. Colquitt AS, Miles EA, Calder PC. Do probiotics in pregnancy reduce allergies and asthma in infancy and childhood? A systematic review. Nutrients. 2022;14(9):1852. doi: 10.3390/nu14091852 EDN: VSAKGI
  27. Wang S, Yin P, Yu L, et al. Effects of early diet on the prevalence of allergic disease in children: a systematic review and meta-analysis. Adv Nutr. 2024;15(1):100128. doi: 10.1016/j.advnut.2023.10.001 EDN: YJCDHM
  28. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122(4):788–794. doi: 10.1016/j.jaci.2008.07.011
  29. Wickens K, Black P, Stanley TV, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012;42(7):1071–1079. doi: 10.1111/j.1365-2222.2012.03975.x
  30. Wickens K, Stanley TV, Mitchell EA, et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy. 2013;43(9):1048–1057. doi: 10.1111/cea.12154
  31. Bonnard LC, Sharpe GR, Martin M, et al. Prebiotics and synbiotics in asthma: an integrative review of human trials and murine meta-analysis. Nutrients. 2026;18(4):683. doi: 10.3390/nu18040683 EDN: IQZSXO
  32. Venter C, Meyer RW, Greenhawt M, et al. Role of dietary fiber in promoting immune health: an EAACI position paper. Allergy. 2022;77(11):3185–3198. doi: 10.1111/all.15430 EDN: JYJGDQ
  33. Sdona E, Georgakou AV, Ekström S, Bergström A. Dietary fibre intake in relation to asthma, rhinitis and lung function impairment: a systematic review of observational studies. Nutrients. 2021;13(10):3594. doi: 10.3390/nu13103594 EDN: OIJJAW
  34. Bao Y, Zeng J, Wang L, et al. Dietary intake of different carbohydrate types and asthma risk: a systematic review and meta-analysis. Nutr J. 2025;24(1):179. doi: 10.1186/s12937-025-01233-2
  35. Koumpagioti D, Boutopoulou B, Moriki D, et al. Does adherence to the Mediterranean diet have a protective effect against asthma and allergies in children? A systematic review. Nutrients. 2022;14(8):1618. doi: 10.3390/nu14081618 EDN: BMXBVA
  36. Papamichael MM, Itsiopoulos C, Susanto NH, Erbas B. Does adherence to the Mediterranean dietary pattern reduce asthma symptoms in children? A systematic review of observational studies. Public Health Nutr. 2017;20(15):2722–2734. doi: 10.1017/S1368980017001823
  37. Cuello-Garcia CA, Yepes-Nuñez JJ, Morgano GP, et al. World Allergy Organization-McMaster University guidelines for allergic disease prevention (GLAD-P): prebiotics. World Allergy Organ J. 2016;9(1):102. doi: 10.1186/s40413-016-0102-7 EDN: XYXBET
  38. Xie Q, Yuan J, Wang Y. Treating asthma patients with probiotics: a systematic review and meta-analysis. Nutr Hosp. 2023;40(4):829–838. doi: 10.20960/nh.04360
  39. Huang CF, Chie WC, Wang IJ. Efficacy of Lactobacillus administration in school-age children with asthma: a randomized, placebo-controlled trial. Nutrients. 2018;10(11):1678. doi: 10.3390/nu10111678
  40. Kim YC, Sohn KH, Kang HR. Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches. Korean J Intern Med. 2024;39(5):746–758. doi: 10.3904/kjim.2023.451 EDN: XSOIFK
  41. Williams LM, Stoodley IL, Berthon BS, Wood LG. The effects of prebiotics, synbiotics, and short-chain fatty acids on respiratory tract infections and immune function: a systematic review and meta-analysis. Adv Nutr. 2022;13(1):167–192. doi: 10.1093/advances/nmab114 EDN: AASWWF
  42. Jiang Z, Zhu J, Shen Z, et al. The microecological-immune axis in pediatric allergic diseases: imbalance mechanisms and regulatory interventions. Nutrients. 2025;17(18):2925. doi: 10.3390/nu17182925 EDN: HHPXNQ
  43. de Boer GM, Żółkiewicz J, Strzelec KP, et al. Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis. Eur Respir Rev. 2020;29(158):1–13. doi: 10.1183/16000617.0175-2019 EDN: MKAAZQ
  44. de Boer GM, Braunstahl GJ, van Der Ploeg EK, et al. Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: a double-blind placebo-controlled trial. Clin Exp Allergy. 2021;51(9):1172–1184. doi: 10.1111/cea.13990 EDN: PTBENI
  45. Li C, Zhou H, Zhang W, Che D. Bacterial lysate treatment in allergic disease: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2021;32(8):1813–1823. doi: 10.1111/pai.13572 EDN: STOCWX
  46. Esposito S, Soto-Martinez ME, Feleszko W, et al. Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence. Curr Opin Allergy Clin Immunol. 2018;18(3):198–209. doi: 10.1097/ACI.0000000000000433 EDN: YGRMVF
  47. Zhou W, Tang J. Prevalence and risk factors for childhood asthma: a systematic review and meta-analysis. BMC Pediatr. 2025;25(1):50. doi: 10.1186/s12887-025-05409-x EDN: PRVVKB
  48. Yang L, Fu J, Zhou Y. Research progress in atopic march. Front Immunol. 2020;11:1907. doi: 10.3389/fimmu.2020.01907 EDN: FBSCAA
  49. Jolliffe DA, Camargo CA, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes Endocrinol. 2025;13(4):307–320. doi: 10.1016/s2213-8587(24)00348-6 EDN: SPFCTR
  50. Liu A, Ma T, Xu N, et al. Adjunctive probiotics alleviates asthmatic symptoms via modulating the gut microbiome and serum metabolome. Microbiol Spectr. 2021;9(2):e0085921. doi: 10.1128/Spectrum.00859-21 EDN: CAZJOR

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Methodology for sources selection.

Download (198KB)
3. Fig. 2. Formation of the gut microbiome. HMO, human milk oligosaccharides; ОШ, odds ratio.

Download (350KB)
4. Fig. 3. Patient selection criteria for microbiome-oriented therapy. ИКС/ДДБА, inhaled corticosteroids/long-acting β₂-agonists; ЖКТ, gastrointestinal tract; СРК, irritable bowel syndrome; ВЗК, inflammatory bowel disease; ОШ, odds ratio; КЦЖК, short-chain fatty acids.

Download (435KB)

Copyright (c) 2026 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 70763 от 21.08.2017 г.